Effect of EME1 exon variant Ile350Thr on risk and early onset of breast cancer in southern Chinese women

Journal of Biomedical Research

Volumn 27, Issue 3, 2013, Pages 193-201

  Zhao, Jianwei ^a,b   Liu, Lin ^a   Zhang, Anqing ^c   Chen, Qin ^a   Fang, Wenxiang ^a   Zeng, Lizhi ^a   Lu, Jiachun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Baiyun Women and Children Hospital   (China)

^c GUANGDONG WOMEN AND CHILDREN HOSPITAL   (China)

Author keywords

Breast cancer; Early onset; EME1; Exon variant

Indexed keywords

DEOXYRIBONUCLEASE I; ESSENTIAL MEIOTIC ENDONUCLEASE 1 HOMOLOG 1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CHINESE; CONTROLLED STUDY; EARLY CANCER; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84915771450     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20130013     Document Type: Article

References (42)

1. Benson JR, Jatoi I. The global breast cancer burden. Future Oncol 2012, 8: 697-702.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61: 69-90.
3. Zhang ML, Huang ZZ, Zheng Y Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi (in Chinese) 2012, 33: 1049-51.
4. Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, et al. A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 2011; 11: 364.
5. De Luca A, Sanna F, Sallese M, Ruggiero C, Grossi M, Sacchetta P, et al. Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype. Proc Natl Acad Sci U S A 2010; 107: 18628-33.
6. Yaffe MJ, Mainprize JG. Risk of Radiation-induced Breast Cancer from Mammographic Screening. Radiology 2011; 258: 98-105.
7. Kutanzi KR, Koturbash I, Bronson RT, Pogribny IP, Kovalchuk O. Imbalance between apoptosis and cell proliferation during early stages of mammary gland carcinogenesis in ACI rats. Mutat Res 2010; 694(1-2):1-6.
8. Duale N, Olsen AK, Christensen T, Butt ST, Brunborg G. Octyl methoxycinnamate modulates gene expression and prevents cyclobutane pyrimidine dimer formation but not oxidative DNA damage in UV-exposed human cell lines. Toxicol Sci 2010; 114: 272-84.
9. World Health Organization. Guidelines for management of breast cancer 2006.
10. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in nonHispanic white women < or = 55 years. Carcinogenesis 2006; 27: 2209-16.
11. Greenberg RA. Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network. Chromosoma 2008; 117: 305-17.
12. Thompson LH, Schild D. Recombinational DNA repair and human disease. Mutat Res 2002; 509: 49-78.
13. Nikkila J, Coleman KA, Morrissey D, Pylkas K, Erkko H, Messick TE, et al. Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. Oncogene 2009; 28: 1843-52.
14. Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18: 99-113.
15. Machella N, Terry MB, Zipprich J, Gurvich I, Liao Y, Senie RT, et al. Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. Carcinogenesis 2008; 29: 1367-72.
16. Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS. Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells. J Biomed Res 2010; 6: 424-35.
17. Rassool FV, Tomkinson AE. Targeting abnormal DNA double strand break repair in cancer. Cell Mol Life Sci 2010; 67: 3699-710.
18. Mao Z, Jiang Y, Liu X, Seluanov A, Gorbunova V. DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 2009; 11: 683-91.
19. Inagaki A, Schoenmakers S, Baarends WM. DNA double strand break repair, chromosome synapsis and transcriptional silencing in meiosis. Epigenetics 2010; 5: 255-66.
20. Chapman JR, Taylor MR, Boulton SJ. Playing the end game. DNA double-strand break repair pathway choice. Mol Cell 2012; 47: 497-510.
21. Ouyang KJ, Woo LL, Ellis NA. Homologous recombination and maintenance of genome integrity. cancer and aging through the prism of human RecQ helicases. Mech Ageing Dev 2008; 129: 425-40.
22. Lu J, Hu Z, Wei S, Wang LE, Liu Z, El-Naggar AK, et al. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 2009; 30: 1717-21.
23. Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q. 172G > T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 2007; 28: 988-94.
24. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, et al. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged < or = 55 years. Breast Cancer Res Treat 2008; 110: 357-66.
25. Abraham J, Lemmers B, Hande MP, Moynahan ME, Chahwan C, Ciccia A, et al. Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J 2003; 22: 6137-47.
26. Kobayashi J, Iwabuchi K, Miyagawa K, Sonoda E, Suzuki K, Takata M, et al. Current topics in DNA doublestrand break repair. J Radiat Res 2008; 49: 93-103.
27. Geuting V, Kobbe D, Hartung F, Durr J, Focke M, Puchta H. Two distinct MUS81-EME1 complexes from Arabidopsis process Holliday junctions. Plant Physiol 2009; 150: 1062-71.
28. Taylor ER, McGowan CH. Cleavage mechanism of human Mus81-Eme1 acting on Holliday-junction structures. Proc Natl Acad Sci U S A 2008; 105: 3757-62.
29. Ehmsen KT, Heyer WD. A junction branch point adjacent to a DNA backbone nick directs substrate cleavage by Saccharomyces cerevisiae Mus81-Mms4. Nucleic Acids Res 2009; 37: 2026-36.
30. Hiyama T, Katsura M, Yoshihara T, Ishida M, Kinomura A, Tonda T, et al. Haploinsufficiency of the Mus81Eme1 endonuclease activates the intra-S-phase and G2/M checkpoints and promotes rereplication in human cells. Nucleic Acids Res 2006; 34: 880-92.
31. Tomoda Y, Katsura M, Okajima M, Hosoya N, Kohno N, Miyagawa K. Functional evidence for Eme1 as a marker of cisplatin resistance. Int J Cancer 2009; 124: 2997-3001.
32. Chang JH, Kim JJ, Choi JM, Lee JH, Cho Y. Crystal structure of the Mus81-Eme1 complex. Genes Dev 2008; 22: 1093-106.
33. Chang JS, Yeh RF, Wiencke JK, Wiemels JL, Smirnov I, Pico AR, et al. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev 2008; 17: 1368-73.
34. Zheng J, Jiang L, Zhang L, Yang L, Deng J, You Y, et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis 2012; 33: 2409-16.
35. Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, et al. CD44 rs13347 C > T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 2012; 14: R105.
36. Liu B, Yang L, Huang B, Cheng M, Wang H, Li Y, et al. A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer. Am J Hum Genet 2012; 91: 384-90.
37. Huang B, Liu B, Yang L, Li Y, Cheng M, Huang D, et al. Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese. Int J Cancer 2012; 131: E744-758.
38. Yang L, Li Y, Cheng M, Huang D, Zheng J, Liu B, et al. A functional polymorphism at microRNA-629binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis 2012; 33: 338-47.
39. Lu J, Yang L, Zhao H, Liu B, Li Y, Wu H, et al. The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat 2011; 32: 1299-308.
40. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false. an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434-42.
41. Yue P, Melamud E, Moult J. SNPs3D. candidate gene and SNP selection for association studies. BMC Bioinformatics 2006; 7: 166.
42. Wacholder S CS, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false. an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434-42.